Benjamin Harshbarger Net Worth

Benjamin Harshbarger biography

Benjamin Scott Harshbarger serves as Senior Vice President, General Counsel of the Company. Mr. Harshbarger most recently served as the Interim Chief Executive Officer and General Counsel at Novelion Therapeutics, Inc., the parent company of Aegerion Pharmaceuticals, Inc. Prior to that, he served in several legal roles at Aegerion Pharmaceuticals, Inc., including as Deputy General Counsel, VP, EMEA Legal Counsel, and Acting General Counsel and General Counsel. As Acting General Counsel and General Counsel, he played a critical role in revamping Aegerion's compliance program. Mr. Harshbarger has also held senior legal positions at Cubist Pharmaceuticals, Inc., Viacell, Inc. and Biogen, Inc. Mr. Harshbarger holds his JD from Boston College Law School, and his BA from the University of Richmond.

What's Benjamin Harshbarger's mailing address?

Benjamin's mailing address filed with the SEC is 1800 W Georgia St, Vancouver, BC V6G 2L3, Canada.

Insiders trading at Astria Therapeutics Inc

Over the last 9 years, insiders at Astria Therapeutics Inc have traded over $0 worth of Astria Therapeutics Inc stock and bought 3,064,797 units worth $36,777,564 . The most active insiders traders include Jean George, Nicholas Galakatos und Lifesciences Ii, L.P.Clarus.... On average, Astria Therapeutics Inc executives and independent directors trade stock every 0 days with the average trade being worth of $2,617,339. The most recent stock trade was executed by Lifesciences Ii, L.P.Clarus... on 30 June 2015, trading 376,695 units of CATB stock currently worth $4,520,340.

What does Astria Therapeutics Inc do?

Astria Therapeutics Inc executives and stock owners

Astria Therapeutics Inc executives and other stock owners filed with the SEC include:

• Jill Milne,
  President, Chief Executive Officer, Co-Founder, Director
• Joanne Donovan,
  Chief Medical Officer
• Andrew Nichols,
  Chief Scientific Officer
• Kenneth Bate,
  Independent Chairman of the Board
• Michael Kishbauch,
  Independent Director
• Gregg Lapointe,
  Independent Director
• Burt Adelman,
  Independent Director
• Hugh Cole,
  Independent Director
• Joanne Beck,
  Independent Director
• Andrew Komjathy,
  Chief Commercial Officer
• Benjamin Harshbarger,
  Senior Vice President, General Counsel
• Noah Clauser,
  Chief Financial Officer
• Andrea Matthews,
  IR Contact Officer
• Rick Modi,
  Chief Business Officer
• Jean George,
  Director
• V, Llcsv Life Sciences Fund...,
  
• Ron Laufer,
  Director
• Michael Jay Ross,
  Director
• Michael Jirousek,
  Chief Scientific Officer
• Lifesciences Ii, L.P.Clarus...,
  
• Ian C. Sanderson,
  Chief Financial Officer
• Ventures, Inc. Med Immune,
  10% owner
• Nicholas Galakatos,
  Director
• Edward K. Hibben,
  Chief Business Officer
• Fred Callori,
  Director
• Jonathan Violin,
  Director
• Deirdre A. Cunnane,
  Chief Legal Officer
• Advisors Llcperceptive Life...,